Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
BioLight Life Sciences Ltd. (BOLT) | Feltl and Company/ Rodman & Renshaw a unit of H.C. Wainwright & Co.) | $10.00 | n.a. | |||
Sensus Healthcare (SRTS) | Joseph Gunnar/ Neidiger, Tucker, Bruner | $23.00 | n.a. | |||
US Foods Holding (USFD) | TBA | $100.00 | n.a. | |||
n.a. (not available) | ||||||
TBA (to be announced) | ||||||
Postponed | ||||||
Advanced Disposal Services (ADSW) | Deutsche Bank Securities/ Credit Suisse/ Barclays | 21.43 | $20.00 | $22.00 | $450.00 | 1-Star |
Nordic Realty Trust (NORT) | Wunderlich Securities | 5.00 | $15.00 | $15.00 | $75.00 | 1-Star |
OTG EXP (OTG ) | Morgan Stanley/ Credit Suisse/ Barclays/ BMO Capital Markets | 32.50 | $16.00 | $18.00 | $552.50 | 1-Star |
Shimmick Construction (SCCI) | FBR | 6.25 | $11.00 | $13.00 | $75.00 | 1-Star |
Withdrawn | ||||||
Apellis Pharmaceuticals (APLS) | Citigroup/ Barclays/ Leerink Partnera | $86.25 | n.a. | |||
Ellipse Technologies (MGEC) | Piper Jaffray/ William Blair/ Canaccord Genuity | $75.00 | n.a. | |||
New Terms | ||||||
None | ||||||
IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
Week of Feb. 8, 2016 | Manager(s) | Offered | Raised | Price | 2/12/16 | Change |
AveXis (AVXS) | Goldman Sachs/ Jefferies | 4.75 | $95.00 | $20.00 | $17.80 | -11.00% |
Proteostasis Therapeutics (PTI) | Leerink Partners/ BC Capital Markets | 6.25 | $50.00 | $8.00 | $6.18 | -22.75% |